Claim Details
View detailed information about this claim and its related sources.
Claim Information
Complete details about this extracted claim.
- Claim Text
-
Doctors will benefit from the decision since a large share of them — 45 percent in group practices and likely many more in other areas of medicine — are bound by noncompetes.
- Simplified Text
-
Doctors will benefit from FTC decision 45 percent in group practices are bound by noncompetes
- Confidence Score
- 0.900
- Claim Maker
- The author
- Context Type
- News Article
- Context Details
-
{ "agency": "Federal Trade Commission", "agreement": "noncompete agreements", "statistic": "45 percent", "profession": "doctors" } - Subject Tags
- UUID
- 9fdb012b-583b-4b79-8906-962cc4f9d389
- Vector Index
- ✗ No vector
- Created
- September 11, 2025 at 10:27 PM (8 hours ago)
- Last Updated
- September 11, 2025 at 10:27 PM (8 hours ago)
Original Sources for this Claim (1)
All source submissions that originally contained this claim.
51
claims
🔥
8 hours ago
https://www.politico.com/newsletters/politico-pulse/2024/04/24/pharma-lobbying-up-in-2024-00153996
Pharmaceutical industry lobbying spending surged in Q1 2024. Increased spending focuses on PBM reform and other congressional issues. This follows recent government funding bill negotiations.
Similar Claims (0)
Other claims identified as semantically similar to this one.
No similar claims found
This claim appears to be unique in the system.